Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method

While sorafenib (SFN) is the established worldwide standard therapeutic agent for advanced hepatocellular carcinoma (HCC), hepatic arterial infusion chemotherapy (HAIC) is also considered a favorable treatment for some advanced HCCs. This study aimed to evaluate each treatment and provide an optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukubayashi, Kotaro, Tanaka, Motohiko, Izumi, Kazuhiro, Watanabe, Takehisa, Fujie, Satomi, Kawasaki, Takeshi, Yoshimaru, Yoko, Tateyama, Masakuni, Setoyama, Hiroko, Naoe, Hideaki, Kikuchi, Ken, Sasaki, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559033/
https://www.ncbi.nlm.nih.gov/pubmed/26044168
http://dx.doi.org/10.1002/cam4.476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559033/
https://www.ncbi.nlm.nih.gov/pubmed/26044168
http://dx.doi.org/10.1002/cam4.476

Ejemplares similares